http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105732765-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68f068d5cd5a8559000752c8796028c9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-052
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-065
filingDate 2016-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9baa19f9ffd42728e5bdb1d56c89cbad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fb8957a21d6e317ab4551701277ac12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c602883c9b54640876604870147c96fb
publicationDate 2016-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105732765-A
titleOfInvention New synthesis method of hepatitis C drug velpatasvir
abstract The present invention provides a new synthesis method for the hepatitis C drug velpatasvir, which uses two intermediate compounds 4 and compound III to synthesize velpatasvir. The structures of the two compounds are as follows: Among them, the PG group is tert-butoxycarbonyl (Boc), benzyloxycarbonyl (Cbz), acetyl, benzoyl or (S)-2-methoxycarbonylamino-3-methyl-butyryl (Moc- L-Valyl).
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107674064-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107655986-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107573355-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108276421-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110698489-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107501280-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113072615-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113072615-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111018870-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111018870-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110698489-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107759577-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107759577-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107573355-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107674062-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107674062-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107674064-B
priorityDate 2016-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015191437-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104918943-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468027165
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466381397
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467898396
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467342957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467740668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467462919

Total number of triples: 40.